Company Ticker News February 8, 2022Creso Pharma subsidiary on official list to provide psilocybin to Canadian doctors 0 0 Share
Company Ticker News February 4, 2022Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs 0 0 Share
Company Ticker News February 3, 2022Creso Pharma pushes into US CBD market with revenue-generating acquisition 0 0 Share
Company Ticker News January 25, 2022Creso Pharma psychedelics subsidiary Halucenex lodges CTA to test efficacy of psilocybin on treatment-resistant PTSD 0 0 Share
Company Ticker News January 17, 2022Creso Pharma has eye on North America with new crop of cannabis-credentialled executives 0 0 Share
Company Ticker News January 11, 2022Creso Pharma subsidiary Halucenex invited to become Special Access Program drug supplier in Canada 0 0 Share
Press Release December 2, 2021Creso Pharma subsidiary secures upgrade to its Controlled Drugs and Substances Dealer's Licence 0 0 Share
Company Ticker News November 15, 2021Creso Pharma completes integration of Creso ImpACTIVE Ltd assets as it continues to broaden US horizons 0 0 Share
Company Ticker News November 11, 2021Creso Pharma delivers 126% revenue growth in Switzerland with more purchase orders on the way 0 0 Share
